BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25647836)

  • 1. CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia.
    Arieta Kuksin C; Gonzalez-Perez G; Minter LM
    Blood; 2015 Mar; 125(13):2087-94. PubMed ID: 25647836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CXCR4 on T-cell subsets and Plasma IL-17 Concentrations in Patients with Aplastic Anaemia.
    Niu Q; Zhou Q; Liu Y; Jiang H
    Sci Rep; 2017 Aug; 7(1):9075. PubMed ID: 28831064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.
    Roderick JE; Gonzalez-Perez G; Kuksin CA; Dongre A; Roberts ER; Srinivasan J; Andrzejewski C; Fauq AH; Golde TE; Miele L; Minter LM
    J Exp Med; 2013 Jul; 210(7):1311-29. PubMed ID: 23733784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4, but not CXCR3, drives CD8
    Goedhart M; Gessel S; van der Voort R; Slot E; Lucas B; Gielen E; Hoogenboezem M; Rademakers T; Geerman S; van Buul JD; Huveneers S; Dolstra H; Anderson G; Voermans C; Nolte MA
    Eur J Immunol; 2019 Apr; 49(4):576-589. PubMed ID: 30707456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.
    Lu S; Ge M; Zheng Y; Li J; Feng X; Feng S; Huang J; Feng Y; Yang D; Shi J; Chen F; Han Z
    Stem Cell Res Ther; 2017 Aug; 8(1):178. PubMed ID: 28764810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
    Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
    J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia.
    Shi J; Ge M; Lu S; Li X; Shao Y; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
    Blood; 2012 Aug; 120(8):1624-32. PubMed ID: 22797698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice.
    Tong Q; He S; Xie F; Mochizuki K; Liu Y; Mochizuki I; Meng L; Sun H; Zhang Y; Guo Y; Hexner E; Zhang Y
    J Immunol; 2014 Jun; 192(11):5012-22. PubMed ID: 24760151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced recruitment and hematopoietic reconstitution of bone marrow-derived mesenchymal stem cells in bone marrow failure by the SDF-1/CXCR4.
    Chen L; Li Y; Chen W; Han N; Li K; Guo R; Liu Z; Xiao Y
    J Tissue Eng Regen Med; 2020 Sep; 14(9):1250-1260. PubMed ID: 32633015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Gravano DM; Al-Kuhlani M; Davini D; Sanders PD; Manilay JO; Hoyer KK
    J Autoimmun; 2016 Dec; 75():58-67. PubMed ID: 27453063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients.
    Zeng W; Kajigaya S; Chen G; Risitano AM; Nunez O; Young NS
    Exp Hematol; 2004 Sep; 32(9):806-14. PubMed ID: 15345281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2-mediated metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia.
    Wei HJ; Gupta A; Kao WM; Almudallal O; Letterio JJ; Pareek TK
    J Autoimmun; 2018 Nov; 94():33-44. PubMed ID: 30025621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characterization analysis of pathogenic T cells in immune-mediated aplastic anemia mouse model].
    Jia H; Lin ZH; Li W; Zhang ZP; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):587-593. PubMed ID: 36709137
    [No Abstract]   [Full Text] [Related]  

  • 14. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
    Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High programmed death 1 expression on T cells in aplastic anemia.
    Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
    Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 deficiency augments bone marrow failure in a minor-histocompatibility antigen mismatch lymphocyte infusion model.
    Hollinger MK; Giudice V; Cummings NA; Rivell G; Zhang H; Kajigaya S; Keyvanfar K; Chen J; Feng X; Young NS
    Exp Hematol; 2018 Jun; 62():17-23. PubMed ID: 29524567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.
    Sun W; Wu Z; Lin Z; Hollinger M; Chen J; Feng X; Young NS
    Blood; 2018 Dec; 132(26):2730-2743. PubMed ID: 30361263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8
    Qu Y; Sun Z; Yuan Y; Li Z; Wang F; Wu K; Yu H; Lin Q; Fei H; Chen J; Qian M; Cheng Y; Jiang H; Chen T
    Cell Death Dis; 2022 Jul; 13(7):620. PubMed ID: 35851002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2.
    Ba H; Li B; Li X; Li C; Feng A; Zhu Y; Wang J; Li Z; Yin B
    Int Immunopharmacol; 2017 Mar; 44():143-152. PubMed ID: 28092866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.